Literature DB >> 15452007

Physicians report on patient encounters involving direct-to-consumer advertising.

Joel S Weissman1, David Blumenthal, Alvin J Silk, Michael Newman, Kinga Zapert, Robert Leitman, Sandra Feibelmann.   

Abstract

We surveyed a national sample of 643 physicians on events associated with visits during which patients discussed an advertised drug. Physicians perceived improved communication and education but also thought that direct-to-consumer advertising (DTCA) led patients to seek unnecessary treatments. Physicians prescribed the advertised drug in 39 percent of DTCA visits but also recommended lifestyle changes and suggested other treatments. Referring to visits when the DTCA drug was prescribed, 46 percent said that it was the most effective drug, and 48 percent said that others were equally effective. Prescribing DTCA drugs when other effective drugs are available warrants further study.

Entities:  

Mesh:

Year:  2004        PMID: 15452007     DOI: 10.1377/hlthaff.w4.219

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  28 in total

Review 1.  Benefits and harms of direct to consumer advertising: a systematic review.

Authors:  S Gilbody; P Wilson; I Watt
Journal:  Qual Saf Health Care       Date:  2005-08

2.  Prices, profits, and innovation: examining criticisms of new psychotropic drugs' value.

Authors:  Haiden A Huskamp
Journal:  Health Aff (Millwood)       Date:  2006 May-Jun       Impact factor: 6.301

3.  Pharmacy students' knowledge, attitudes, and evaluation of direct-to-consumer advertising.

Authors:  Rupali K Naik; Matthew E Borrego; Gireesh V Gupchup; Melanie Dodd; Mike R Sather
Journal:  Am J Pharm Educ       Date:  2007-10-15       Impact factor: 2.047

4.  Should Canada allow direct-to-consumer advertising of prescription drugs?: yes.

Authors:  Durhane Wong-Rieger
Journal:  Can Fam Physician       Date:  2009-02       Impact factor: 3.275

5.  Rethinking medical professionalism: the role of information technology and practice innovations.

Authors:  David Mechanic
Journal:  Milbank Q       Date:  2008-06       Impact factor: 4.911

6.  To ban or not to ban? Clinical geneticists' views on the regulation of direct-to-consumer genetic testing.

Authors:  Heidi Carmen Howard; Pascal Borry
Journal:  EMBO Rep       Date:  2012-08-14       Impact factor: 8.807

7.  Seniors' perceptions of prescription drug advertisements: a pilot study of the potential impact on informed decision making.

Authors:  Jerry L Grenard; Visith Uy; José A Pagán; Dominick L Frosch
Journal:  Patient Educ Couns       Date:  2010-11-01

8.  Trends in the ambulatory management of headache: analysis of NAMCS and NHAMCS data 1999-2010.

Authors:  John N Mafi; Samuel T Edwards; Nigel P Pedersen; Roger B Davis; Ellen P McCarthy; Bruce E Landon
Journal:  J Gen Intern Med       Date:  2015-01-08       Impact factor: 5.128

9.  Factors affecting physicians' responses to patients' requests for antidepressants: focus group study.

Authors:  Aleksey Tentler; Jordan Silberman; Debora A Paterniti; Richard L Kravitz; Ronald M Epstein
Journal:  J Gen Intern Med       Date:  2007-11-07       Impact factor: 5.128

10.  Ethical and epistemic issues in direct-to-consumer drug advertising: where is patient agency?

Authors:  Catherine A Womack
Journal:  Med Health Care Philos       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.